|
humans |
40 |
|
female |
29 |
|
microbiology |
29 |
|
male |
28 |
|
biofilm |
26 |
|
adult |
24 |
|
middle aged |
24 |
|
mouth - microbiology |
20 |
|
aged |
18 |
|
candida albicans |
15 |
|
fungi |
15 |
|
cohort studies |
14 |
|
polymerase chain reaction |
14 |
|
adolescent |
13 |
|
candida |
13 |
|
follow-up studies |
13 |
|
genotype |
13 |
|
hong kong |
13 |
|
bacteria |
12 |
|
biofilms |
12 |
|
caries |
12 |
|
colony count, microbial |
12 |
|
infection |
12 |
|
oral health |
12 |
|
periodontal index |
12 |
|
antimicrobial agents/inhibitors |
11 |
|
dentistry |
11 |
|
medical sciences |
11 |
|
molecular biology |
11 |
|
oral hygiene |
11 |
|
risk factors |
11 |
|
animals |
10 |
|
anti-bacterial agents - pharmacology |
10 |
|
cell adhesion |
10 |
|
chinese |
10 |
|
dmf index |
10 |
|
statistics, nonparametric |
10 |
|
age factors |
9 |
|
aged, 80 and over |
9 |
|
antifungal agents - pharmacology |
9 |
|
dna, bacterial - analysis |
9 |
|
immunocompromised host |
9 |
|
longitudinal studies |
9 |
|
proteomics |
9 |
|
saliva |
9 |
|
yeasts |
9 |
|
biofilms - drug effects |
8 |
|
biofilms - growth & development |
8 |
|
china |
8 |
|
china - ethnology |
8 |
|
diabetes mellitus, type 2 - complications |
8 |
|
drug combinations |
8 |
|
health status |
8 |
|
prospective studies |
8 |
|
aids-related opportunistic infections - microbiology |
7 |
|
candida glabrata |
7 |
|
cardiovascular disease |
7 |
|
chlorhexidine |
7 |
|
culture media |
7 |
|
dental caries |
7 |
|
enterobacteriaceae - isolation & purification |
7 |
|
epidemiology |
7 |
|
gene expression |
7 |
|
gram-negative aerobic rods and cocci - classification |
7 |
|
gram-negative facultatively anaerobic rods - classification |
7 |
|
hydrogen-ion concentration |
7 |
|
internet in education. |
7 |
|
periodontal disease |
7 |
|
problem-based learning. |
7 |
|
statistics as topic |
7 |
|
therapeutics |
7 |
|
university of hong kong. faculty of dentistry. |
7 |
|
adhesion |
6 |
|
antifungal agents - therapeutic use |
6 |
|
antimicrobial |
6 |
|
bacterial adhesion |
6 |
|
behavioral science |
6 |
|
biofilms - growth and development |
6 |
|
calcium hydroxide |
6 |
|
candida albicans - isolation & purification |
6 |
|
candidiasis - microbiology |
6 |
|
candidiasis, oral - microbiology |
6 |
|
case-control studies |
6 |
|
chinese medicine |
6 |
|
cross-professional |
6 |
|
dental caries - microbiology |
6 |
|
dental plaque - microbiology |
6 |
|
dental pulp cavity - microbiology |
6 |
|
drug resistance, fungal - genetics |
6 |
|
drugs, chinese herbal - chemistry - pharmacology |
6 |
|
drugs, chinese herbal - pharmacology |
6 |
|
fructus mume |
6 |
|
gene expression regulation, fungal |
6 |
|
genetic variation |
6 |
|
glucose - metabolism |
6 |
|
health services research and learning |
6 |
|
hiv infection |
6 |
|
mouth mucosa - microbiology |
6 |
|
mouthrinses |
6 |
|
orthodontic |
6 |
|
orthodontic brackets - microbiology |
6 |
|
orthodontics |
6 |
|
periapical periodontitis - microbiology |
6 |
|
phenotype |
6 |
|
plant extracts - analysis - pharmacology |
6 |
|
porphyromonas gingivalis - drug effects |
6 |
|
pseudomonas - isolation & purification |
6 |
|
yeast |
6 |
|
actinomyces |
5 |
|
actinomyces - classification - isolation & purification |
5 |
|
amino acid sequence |
5 |
|
anti-infective agents, local - administration and dosage - pharmacology |
5 |
|
antibiotics |
5 |
|
antimicrobial effect |
5 |
|
antimicrobials |
5 |
|
apical periodontitis |
5 |
|
artificial mouth |
5 |
|
aspergillosis |
5 |
|
attitude to health |
5 |
|
bacteria, anaerobic - drug effects - isolation & purification |
5 |
|
bacterial typing techniques |
5 |
|
biofilms - drug effects - growth & development |
5 |
|
blood glucose - analysis |
5 |
|
bone marrow transplantation |
5 |
|
calcium chloride |
5 |
|
calcium hydroxide - pharmacology |
5 |
|
canavalia |
5 |
|
candida - classification |
5 |
|
candida - growth & development - metabolism |
5 |
|
candida - isolation & purification |
5 |
|
candida albicans - enzymology - isolation & purification |
5 |
|
candida albicans - growth & development |
5 |
|
candida albicans - growth & development - physiology - ultrastructure |
5 |
|
candida albicans - pathogenicity |
5 |
|
candida biofilms |
5 |
|
candida species |
5 |
|
candidiasis, oral - epidemiology - microbiology |
5 |
|
chemicals and cas registry numbers |
5 |
|
child |
5 |
|
children |
5 |
|
chlorhexidine - administration and dosage - analogs and derivatives - pharmacology |
5 |
|
confocal scanning laser microscope |
5 |
|
cross-sectional studies |
5 |
|
cyclosporine - therapeutic use |
5 |
|
cytokine |
5 |
|
demeclocycline - pharmacology |
5 |
|
diabetes complications |
5 |
|
diabetes mellitus |
5 |
|
dietary sucrose - metabolism |
5 |
|
differentiation |
5 |
|
diffusion |
5 |
|
disease progression |
5 |
|
drug resistance, fungal |
5 |
|
elderly |
5 |
|
electrophoresis, gel, pulsed-field |
5 |
|
endodontic treatment |
5 |
|
enteric rods |
5 |
|
enterobacteriaceae - classification |
5 |
|
erythrina |
5 |
|
galactose - metabolism |
5 |
|
gingival overgrowth - chemically induced - classification |
5 |
|
gingivitis |
5 |
|
gram-negative bacteria - drug effects |
5 |
|
gram-negative facultatively anaerobic rods - isolation & purification |
5 |
|
gram-positive bacteria - drug effects |
5 |
|
gram-positive rods - isolation & purification |
5 |
|
hatr-ftir |
5 |
|
hemoglobin a, glycosylated - analysis |
5 |
|
hemolysin proteins - biosynthesis |
5 |
|
hiv infections - complications |
5 |
|
hong kong - epidemiology |
5 |
|
hypertension - complications |
5 |
|
immunohistochemistry |
5 |
|
immunology |
5 |
|
immunosuppressive agents - therapeutic use |
5 |
|
indicators and reagents |
5 |
|
kidney transplantation |
5 |
|
lectins |
5 |
|
microscopy, confocal |
5 |
|
microscopy, confocal - methods |
5 |
|
microscopy, electron, scanning |
5 |
|
mouth |
5 |
|
mouth diseases - microbiology |
5 |
|
mouthwashes - administration and dosage - pharmacology |
5 |
|
mucormycosis |
5 |
|
nasopharyngeal carcinoma |
5 |
|
neomycin - pharmacology |
5 |
|
oral |
5 |
|
oral biofilm |
5 |
|
oral microbiology |
5 |
|
organic chemicals |
5 |
|
peptide hydrolases - biosynthesis |
5 |
|
periodontal attachment loss - complications |
5 |
|
periodontal diseases - therapy |
5 |
|
periodontal organisms |
5 |
|
periodontics |
5 |
|
periodontitis - complications |
5 |
|
plant extracts - pharmacology |
5 |
|
plant lectins |
5 |
|
polymers - analysis |
5 |
|
polymyxin b - pharmacology |
5 |
|
potassium chloride |
5 |
|
poverty |
5 |
|
propidium |
5 |
|
prunus |
5 |
|
quorum sensing |
5 |
|
random amplified polymorphic dna technique |
5 |
|
root canal irrigants - pharmacology |
5 |
|
s. mutans and saliva |
5 |
|
sex factors |
5 |
|
sodium bicarbonate |
5 |
|
sodium chloride |
5 |
|
software |
5 |
|
species specificity |
5 |
|
spectroscopy, fourier transform infrared |
5 |
|
stain |
5 |
|
stenotrophomonas maltophilia |
5 |
|
stenotrophomonas maltophilia - isolation & purification |
5 |
|
steroid |
5 |
|
stroke |
5 |
|
sucrose - metabolism |
5 |
|
sugars |
5 |
|
tacrolimus - therapeutic use |
5 |
|
tibetans |
5 |
|
transplantation, homologous |
5 |
|
triamcinolone acetonide - pharmacology |
5 |
|
type 2 diabetes mellitus |
5 |
|
tyrothricin - pharmacology |
5 |
|
2-d dige |
4 |
|
2-de |
4 |
|
acinetobacter - classification |
4 |
|
actinobacillus actinomycetemcomitans - isolation & purification |
4 |
|
actinomyces - isolation & purification - physiology - ultrastructure |
4 |
|
actinomycetes |
4 |
|
actinomycosis - microbiology |
4 |
|
adhesion and aggregation |
4 |
|
adult periodontitis |
4 |
|
animal |
4 |
|
anti-oxidant activity |
4 |
|
antifungal |
4 |
|
antioxidants - physiology |
4 |
|
architecture |
4 |
|
asian continental ancestry group |
4 |
|
atomic force microscopy |
4 |
|
bacteremia - epidemiology - microbiology |
4 |
|
bacteria - classification - growth & development |
4 |
|
bacteria - classification - isolation & purification |
4 |
|
bacteria - drug effects |
4 |
|
bacteria, anaerobic - isolation & purification |
4 |
|
bacterial infections - microbiology |
4 |
|
bacterial physiological phenomena |
4 |
|
bacteriological techniques |
4 |
|
bacteroides - isolation & purification |
4 |
|
biodiversity |
4 |
|
biofilms - drug effects - growth and development |
4 |
|
biomarker |
4 |
|
biomass |
4 |
|
biophysical phenomena |
4 |
|
biophysics |
4 |
|
biopsy |
4 |
|
c. albicans |
4 |
|
candida - drug effects |
4 |
|
candida - growth and development - metabolism - physiology |
4 |
|
candida - pathogenicity |
4 |
|
candida albicans - drug effects |
4 |
|
candida albicans - genetics - pathogenicity - ultrastructure |
4 |
|
candida albicans - physiology |
4 |
|
candida glabrata - drug effects - genetics - metabolism - physiology |
4 |
|
candida glabrata - growth & development |
4 |
|
candida krusei |
4 |
|
candida tropicalis |
4 |
|
candidiasis, oral - physiopathology |
4 |
|
carcinoma - complications - radiotherapy |
4 |
|
carcinoma - radiotherapy |
4 |
|
carcinoma in situ - genetics |
4 |
|
carcinoma, squamous cell - genetics |
4 |
|
caries risk |
4 |
|
cariology and fluoride |
4 |
|
carrier state - microbiology |
4 |
|
cell membrane - microbiology |
4 |
|
cell wall - chemistry |
4 |
|
cftr |
4 |
|
chromosomes, human, pair 21 - genetics |
4 |
|
citrobacter - classification |
4 |
|
clonality |
4 |
|
coliforms |
4 |
|
collagen and demineralization |
4 |
|
collagen i |
4 |
|
confidence intervals |
4 |
|
cystic fibrosis transmembrane conductance regulator - analysis - genetics - metabolism |
4 |
|
demineralization |
4 |
|
dental care |
4 |
|
dental pulp diseases - microbiology |
4 |
|
dental pulp exposure - microbiology |
4 |
|
dental pulp necrosis - microbiology |
4 |
|
dentists |
4 |
|
dentures |
4 |
|
dentures - adverse effects |
4 |
|
dinoprostone - analysis - metabolism |
4 |
|
disease outbreaks |
4 |
|
diversity |
4 |
|
dna, neoplasm - genetics |
4 |
|
drug resistance, bacterial |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
ecology |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
endocarditis - epidemiology - microbiology |
4 |
|
enterobacter - classification |
4 |
|
enterobacteriaceae |
4 |
|
enterococcus faecalis |
4 |
|
escherichia - classification |
4 |
|
ethnic groups |
4 |
|
fimbriae |
4 |
|
flavobacterium - classification |
4 |
|
fungi - drug effects - physiology |
4 |
|
gene expression profiling |
4 |
|
genes, tumor suppressor |
4 |
|
genotypes |
4 |
|
gingiva - metabolism - pathology |
4 |
|
gingiva - microbiology |
4 |
|
gingival crevice |
4 |
|
gingival crevicular fluid |
4 |
|
gingival crevicular fluid - immunology - metabolism |
4 |
|
gingival epithelium |
4 |
|
glycolysis |
4 |
|
gram-negative bacteria - chemistry |
4 |
|
granulocyte elastase |
4 |
|
growth kinetics |
4 |
|
health knowledge, attitudes, practice |
4 |
|
hela cells |
4 |
|
image analysis |
4 |
|
immunology and microbiology |
4 |
|
incidence |
4 |
|
inflammation |
4 |
|
inflammatory mediators |
4 |
|
interaction force |
4 |
|
irradiation |
4 |
|
issatchenkia orientalis |
4 |
|
klebsiella - classification |
4 |
|
klebsiella pneumoniae - classification |
4 |
|
lactobacilli |
4 |
|
leukocyte elastase - analysis - metabolism |
4 |
|
lipopolysaccharides - isolation and purification - metabolism |
4 |
|
loss of heterozygosity |
4 |
|
lysozyme |
4 |
|
metagenome |
4 |
|
metagenomics |
4 |
|
microbial sensitivity tests |
4 |
|
microbial viability |
4 |
|
microbiology and nucleic acids |
4 |
|
microsatellite repeats |
4 |
|
microscopy, atomic force |
4 |
|
microscopy, fluorescence |
4 |
|
mouth - microbiology - radiation effects |
4 |
|
mouth mucosa - cytology - microbiology |
4 |
|
mouth neoplasms - genetics |
4 |
|
mouthwashes - therapeutic use |
4 |
|
nasopharyngeal neoplasms - complications - radiotherapy |
4 |
|
nasopharyngeal neoplasms - radiotherapy |
4 |
|
neisseria - classification |
4 |
|
neoplasm invasiveness - genetics |
4 |
|
neoplasm recurrence, local - genetics |
4 |
|
neoplasm staging |
4 |
|
nucleic acid hybridization |
4 |
|
odds ratio |
4 |
|
oligonucleotide probes |
4 |
|
oligonucleotide-dna hybridization |
4 |
|
oral candidiasis |
4 |
|
oropharynx |
4 |
|
periodontal diseases - microbiology |
4 |
|
periodontitis - enzymology - immunology - microbiology |
4 |
|
periodontopathogen |
4 |
|
pge2 |
4 |
|
phospholipase |
4 |
|
polymorphism, genetic |
4 |
|
polymorphism, restriction fragment length |
4 |
|
polystyrenes |
4 |
|
porphyromonas gingivalis - isolation & purification |
4 |
|
prevotella intermedia - isolation & purification |
4 |
|
proteins |
4 |
|
proteoglycans |
4 |
|
proteomics - methods |
4 |
|
pseudomonas - classification |
4 |
|
rats |
4 |
|
rats, sprague-dawley |
4 |
|
reconstituted human oral epithelium |
4 |
|
rehabilitation |
4 |
|
resistance |
4 |
|
rna, ribosomal, 16s - analysis |
4 |
|
root |
4 |
|
root canal infection |
4 |
|
root-canal bacteria |
4 |
|
sequencing |
4 |
|
species index: candida |
4 |
|
streptococci |
4 |
|
stress response |
4 |
|
stress, physiological |
4 |
|
subgingival plaque |
4 |
|
tooth - microbiology |
4 |
|
tooth diseases - microbiology |
4 |
|
tooth injuries - microbiology |
4 |
|
toothbrushing |
4 |
|
treponema - isolation & purification |
4 |
|
viability |
4 |
|
virulence |
4 |
|
xerostomia |
4 |
|
xerostomia - complications |
4 |
|
xerostomia - etiology - microbiology |
4 |
|
3d cell sheet |
3 |
|
acrylic resins |
3 |
|
actinomyces viscosus - isolation & purification |
3 |
|
adaptation, physiological |
3 |
|
adenosine triphosphate - analysis |
3 |
|
adherence |
3 |
|
adherence and colonization |
3 |
|
aids-related opportunistic infections - drug therapy - microbiology |
3 |
|
amphotericin b |
3 |
|
amphotericin b - therapeutic use |
3 |
|
analysis of variance |
3 |
|
anti-candidal activity |
3 |
|
anti-candidal salivary factors |
3 |
|
antifungal agents - analysis - pharmacology |
3 |
|
antifungal agents - metabolism - pharmacology |
3 |
|
antifungal drug |
3 |
|
antifungal resistance |
3 |
|
antifungal susceptibility |
3 |
|
antifungal susceptibility testing |
3 |
|
antifungals |
3 |
|
antimicrobial activity |
3 |
|
aspartic acid endopeptidases - analysis |
3 |
|
aspirin - therapeutic use |
3 |
|
atp bioluminescence |
3 |
|
autoinducer |
3 |
|
b-lymphocytes - virology |
3 |
|
bacteria - growth & development |
3 |
|
bacterial colonization |
3 |
|
base sequence |
3 |
|
biochemistry |
3 |
|
biology |
3 |
|
bioreactors - standards |
3 |
|
biotypes |
3 |
|
blood-borne pathogens |
3 |
|
bloodstream isolates |
3 |
|
blotting, southern |
3 |
|
blotting, western |
3 |
|
c. albicans biofilms |
3 |
|
candida - classification - drug effects - genetics - isolation & purification |
3 |
|
candida - classification - drug effects - physiology |
3 |
|
candida - drug effects - growth & development |
3 |
|
candida - drug effects - growth & development - isolation & purification |
3 |
|
candida - drug effects - physiology - ultrastructure |
3 |
|
candida - growth & development - physiology |
3 |
|
candida albicans - chemistry - drug effects |
3 |
|
candida albicans - classification - drug effects |
3 |
|
candida albicans - classification - drug effects - genetics - isolation & purification |
3 |
|
candida albicans - classification - drug effects - growth & development |
3 |
|
candida albicans - classification - genetics |
3 |
|
candida albicans - drug effects - growth & development - ultrastructure |
3 |
|
candida albicans - genetics - pathogenicity |
3 |
|
candida carriers and non-carriers |
3 |
|
candida dubliniensis |
3 |
|
candida glabrata - isolation & purification |
3 |
|
candida tropicalis - isolation & purification |
3 |
|
candidiasis |
3 |
|
candidiasis, oral - complications - drug therapy - microbiology - pathology |
3 |
|
candidiasis, oral - complications - epidemiology - microbiology |
3 |
|
candidiasis, oral - complications - microbiology |
3 |
|
candidiasis, oral - drug therapy - microbiology |
3 |
|
candidiasis, oral - immunology |
3 |
|
candidiasis, oral - immunology - microbiology - pathology |
3 |
|
candidiasis, oral - microbiology - pathology |
3 |
|
candidosis |
3 |
|
carbohydrate metabolism |
3 |
|
carcinogen |
3 |
|
carcinoma - microbiology - radiotherapy |
3 |
|
cardiovascular disease and quality of life |
3 |
|
carrier state - epidemiology - microbiology |
3 |
|
carrier state - immunology - microbiology - pathology |
3 |
|
cell biology |
3 |
|
cell culture |
3 |
|
cell line |
3 |
|
cell-cell signaling |
3 |
|
cerebral palsy |
3 |
|
chi-square distribution |
3 |
|
child, preschool |
3 |
|
chinese preschool children |
3 |
|
chronic periodontitis |
3 |
|
clinical effectiveness |
3 |
|
clinical isolates |
3 |
|
cluster analysis |
3 |
|
colony count, microbial - methods |
3 |
|
coronavirus pneumonia infection |
3 |
|
cranial irradiation |
3 |
|
crevicular fluid |
3 |
|
cross infection - prevention & control |
3 |
|
cross infection - prevention & control - psychology - transmission |
3 |
|
cryptococcosis |
3 |
|
cyclophosphamide |
3 |
|
debridement |
3 |
|
dental caries - epidemiology - microbiology |
3 |
|
dental enamel - microbiology |
3 |
|
dental health |
3 |
|
dental office |
3 |
|
dental plaque - epidemiology - microbiology |
3 |
|
dental service, hospital |
3 |
|
denture acrylic |
3 |
|
denture bases - microbiology |
3 |
|
denture cleanliness |
3 |
|
denture hygiene |
3 |
|
denture plaque |
3 |
|
denture, complete, upper - adverse effects |
3 |
|
diagnostics |
3 |
|
diet, vegetarian |
3 |
|
dietary carbohydrates - administration & dosage |
3 |
|
dietary carbohydrates - pharmacology |
3 |
|
disease models, animal |
3 |
|
disinfectants - pharmacology |
3 |
|
dna primers |
3 |
|
dose-response relationship, drug |
3 |
|
drug evaluation, preclinical - methods |
3 |
|
drug resistance, microbial - genetics |
3 |
|
drug synergism |
3 |
|
enzymes |
3 |
|
epithelial cells |
3 |
|
epithelial cells - metabolism - microbiology |
3 |
|
epithelial cells - microbiology |
3 |
|
epithelium - microbiology |
3 |
|
epithelium - microbiology - pathology |
3 |
|
epstein-barr virus |
3 |
|
equipment contamination |
3 |
|
escherichia coli - physiology |
3 |
|
eye protective devices |
3 |
|
fluconazole |
3 |
|
fluconazole - pharmacology |
3 |
|
fluconazole - therapeutic use |
3 |
|
food handling |
3 |
|
fungal proteins - analysis |
3 |
|
fungal proteins - metabolism |
3 |
|
fungi - physiology |
3 |
|
galactose - administration & dosage - metabolism |
3 |
|
gene expression regulation, bacterial |
3 |
|
glucose - administration & dosage - metabolism |
3 |
|
gram-negative bacteria - isolation & purification |
3 |
|
gram-negative rods |
3 |
|
growth & development |
3 |
|
head and neck irradiation |
3 |
|
health promotion |
3 |
|
herpesvirus 4, human - physiology |
3 |
|
histoplasmosis |
3 |
|
hiv infections - complications - microbiology |
3 |
|
hiv infections - microbiology |
3 |
|
hiv-infection |
3 |
|
hospitalization |
3 |
|
hospitals, teaching |
3 |
|
human umbilical vein endothelial cells |
3 |
|
hypha |
3 |
|
hyphae |
3 |
|
image processing, computer-assisted |
3 |
|
immune response |
3 |
|
immunoglobulin a, secretory - analysis |
3 |
|
immunosuppression |
3 |
|
immunosuppressive agents |
3 |
|
indices |
3 |
|
indoles - pharmacology |
3 |
|
infection control, dental - instrumentation - methods |
3 |
|
infectious disease transmission, patient-to-professional - prevention & control |
3 |
|
institutionalization |
3 |
|
interactome |
3 |
|
interviews as topic |
3 |
|
ketoconazole - therapeutic use |
3 |
|
kinetics |
3 |
|
klebsiella pneumoniae - isolation & purification |
3 |
|
lactoferrin - analysis |
3 |
|
lactoferrin - pharmacology |
3 |
|
leprosy - complications |
3 |
|
leukocyte count |
3 |
|
life style |
3 |
|
lipopolysaccharide |
3 |
|
lipopolysaccharides - metabolism - pharmacology |
3 |
|
logistic models |
3 |
|
masks |
3 |
|
metabolism |
3 |
|
metastatsis |
3 |
|
metergoline |
3 |
|
methylmethacrylates - metabolism |
3 |
|
microbial sensitivity tests - methods |
3 |
|
microbiology and oral biology |
3 |
|
microbiology and physiology and biochemistry |
3 |
|
microbiology and plaque |
3 |
|
mouth cavity |
3 |
|
mouth flora |
3 |
|
mouth mucosa - microbiology - pathology |
3 |
|
mouth mucosa - virology |
3 |
|
muramidase - analysis |
3 |
|
muramidase - pharmacology |
3 |
|
mutation |
3 |
|
mycological typing techniques |
3 |
|
mycoses - drug therapy - microbiology - pathology |
3 |
|
nasopharyngeal neoplasms - microbiology - radiotherapy |
3 |
|
neisseriaceae - isolation & purification |
3 |
|
neoplasms - blood supply - chemistry - metabolism - therapy |
3 |
|
new infection |
3 |
|
nystatin - pharmacology |
3 |
|
opportunistic infections - microbiology |
3 |
|
oral biology |
3 |
|
oral health promotion |
3 |
|
oral manifestations |
3 |
|
oral microbial carriage |
3 |
|
oral prevalence |
3 |
|
organosilicon compounds - pharmacology |
3 |
|
oropharynx - microbiology |
3 |
|
orthodontic appliances - adverse effects |
3 |
|
orthodontic appliances - microbiology |
3 |
|
orthodontics - instrumentation |
3 |
|
patient discharge |
3 |
|
periodontal ligament stem cells |
3 |
|
periodontal pocket - microbiology |
3 |
|
periodontium-gingiva |
3 |
|
pharyngeal diseases - microbiology |
3 |
|
phenotypic switching |
3 |
|
photodynamic therapy |
3 |
|
photosensitiser |
3 |
|
photosensitizing agents - pharmacology |
3 |
|
phthalocyanine |
3 |
|
physical disability |
3 |
|
planimetry |
3 |
|
plankton - growth & development |
3 |
|
plaque biofilm |
3 |
|
plasma protein binding |
3 |
|
platelet aggregation inhibitors - therapeutic use |
3 |
|
prevalence |
3 |
|
private practice |
3 |
|
protective devices |
3 |
|
proteome |
3 |
|
proteome - analysis |
3 |
|
pseudomonas |
3 |
|
random allocation |
3 |
|
recurrence |
3 |
|
regeneration |
3 |
|
regeneration and tissue engineering |
3 |
|
regression analysis |
3 |
|
review |
3 |
|
root canal therapy |
3 |
|
root caries |
3 |
|
rotating disc |
3 |
|
saccharomyces cerevisiae - isolation & purification |
3 |
|
saliva - chemistry - microbiology - physiology |
3 |
|
saliva - metabolism |
3 |
|
saliva - microbiology |
3 |
|
secretory rate - physiology |
3 |
|
sequence analysis, dna |
3 |
|
sequential isolates |
3 |
|
serotyping |
3 |
|
severe acute respiratory syndrome - prevention & control - psychology - transmission |
3 |
|
shedding |
3 |
|
signal transduction |
3 |
|
singapore |
3 |
|
south-east asia |
3 |
|
southern hybridization |
3 |
|
spores, fungal - drug effects - growth & development |
3 |
|
staphylococcal infections - complications |
3 |
|
stem cells and tissue engineering |
3 |
|
streptococcus mitis |
3 |
|
streptococcus mutans |
3 |
|
streptococcus sanguis |
3 |
|
stroke - microbiology |
3 |
|
supragingival plaque |
3 |
|
synergism |
3 |
|
time factors |
3 |
|
tissue engineering |
3 |
|
tongue - microbiology - pathology |
3 |
|
tooth, deciduous - microbiology |
3 |
|
toothbrushes |
3 |
|
transforming growth factor beta1 - metabolism |
3 |
|
transforming growth factor-β1 |
3 |
|
vegetarians |
3 |
|
virulence attributes |
3 |
|
virulence factors |
3 |
|
virus shedding - physiology |
3 |
|
virus-loaded aerosol |
3 |
|
xtt reduction assay |
3 |
|
yeasts - isolation & purification |
3 |
|
young adult |
3 |
|
5' flanking region |
2 |
|
absorption layer |
2 |
|
acids - metabolism |
2 |
|
acquired immunodeficiency syndrome - prevention & control - transmission |
2 |
|
acrylic |
2 |
|
actinomyces - classification - genetics |
2 |
|
actinomyces - classification - genetics - pathogenicity |
2 |
|
actinomyces - growth & development - metabolism - pathogenicity |
2 |
|
actinomyces viscosus - classification - genetics |
2 |
|
actinomycosis - drug therapy - microbiology |
2 |
|
acylation |
2 |
|
adenine - metabolism |
2 |
|
adhesive bonding |
2 |
|
aerobiosis |
2 |
|
affinity purification |
2 |
|
africa |
2 |
|
aids |
2 |
|
aids-related opportunistic infections - complications |
2 |
|
amine fluoride |
2 |
|
amphotericin b - antagonists & inhibitors - pharmacology |
2 |
|
amphotericin b - metabolism - pharmacology |
2 |
|
anaerobic |
2 |
|
anaerobiosis |
2 |
|
anemia, hypochromic - etiology |
2 |
|
angular cheilitis |
2 |
|
antagonism |
2 |
|
anti-bacterial agents - therapeutic use |
2 |
|
anti-infective agents - analysis |
2 |
|
anti-infective agents - pharmacology |
2 |
|
antibodies, monoclonal - immunology |
2 |
|
antibodies, protozoan - genetics - immunology |
2 |
|
antifungal agents - antagonists & inhibitors - pharmacology |
2 |
|
antifungal agents - pharmacology - therapeutic use |
2 |
|
antigens, cd1 - analysis |
2 |
|
antigens, cd14 - biosynthesis - genetics |
2 |
|
antigens, protozoan - genetics - immunology |
2 |
|
antigens, surface - immunology |
2 |
|
antiretroviral therapy, highly active - adverse effects |
2 |
|
apoproteins - pharmacology |
2 |
|
appressoria |
2 |
|
areca |
2 |
|
aspartic acid endopeptidases - genetics |
2 |
|
aspartic acid endopeptidases - metabolism |
2 |
|
aspartic endopeptidases - antagonists & inhibitors - metabolism - secretion |
2 |
|
australia - epidemiology |
2 |
|
bacteria - classification - growth & development - isolation & purification |
2 |
|
bacteria - isolation & purification - ultrastructure |
2 |
|
bacteria, aerobic - physiology |
2 |
|
bacteria, anaerobic - physiology |
2 |
|
bacterial adhesion - physiology |
2 |
|
bacterial coaggregation |
2 |
|
bacterial dierentiation |
2 |
|
bacterial proteins - genetics - metabolism |
2 |
|
bacteroidaceae infections - complications - immunology |
2 |
|
beta-defensins - analysis |
2 |
|
beta-defensins - biosynthesis - genetics |
2 |
|
beta-defensins - genetics - metabolism |
2 |
|
biocides |
2 |
|
biological assay |
2 |
|
bisexuality |
2 |
|
buccal epithelial cells |
2 |
|
c. glabrata |
2 |
|
calcium hydroxide - therapeutic use |
2 |
|
candida - classification - drug effects |
2 |
|
candida - classification - drug effects - growth & development - ultrastructure |
2 |
|
candida - classification - genetics - immunology |
2 |
|
candida - classification - isolation & purification |
2 |
|
candida - drug effects - growth & development - pathogenicity |
2 |
|
candida - drug effects - isolation & purification - ultrastructure |
2 |
|
candida - enzymology - growth & development - pathogenicity |
2 |
|
candida - enzymology - pathogenicity - physiology |
2 |
|
candida - genetics - isolation & purification - pathogenicity |
2 |
|
candida - genetics - metabolism - radiation effects |
2 |
|
candida - genetics - pathogenicity |
2 |
|
candida - physiology |
2 |
|
candida - physiology - ultrastructure |
2 |
|
candida albicans - chemistry - genetics - isolation & purification - physiology |
2 |
|
candida albicans - classification |
2 |
|
candida albicans - classification - genetics - isolation & purification |
2 |
|
candida albicans - cytology - drug effects - physiology |
2 |
|
candida albicans - cytology - enzymology - ultrastructure |
2 |
|
candida albicans - drug effects - genetics - growth & development |
2 |
|
candida albicans - drug effects - genetics - growth and development |
2 |
|
candida albicans - drug effects - genetics - isolation & purification |
2 |
|
candida albicans - drug effects - growth & development |
2 |
|
candida albicans - drug effects - physiology |
2 |
|
candida albicans - enzymology - genetics - growth & development - isolation & purification |
2 |
|
candida albicans - enzymology - growth & development - pathogenicity |
2 |
|
candida albicans - genetics - growth & development - isolation & purification - pathogenicity |
2 |
|
candida albicans - genetics - physiology - ultrastructure |
2 |
|
candida albicans - growth and development - ultrastructure |
2 |
|
candida albicans - immunology |
2 |
|
candida albicans - metabolism - pathogenicity |
2 |
|
candida albicans - physiology - ultrastructure |
2 |
|
candida glabrata - physiology - ultrastructure |
2 |
|
candida tropicalis - immunology |
2 |
|
candida tropicalis - physiology - ultrastructure |
2 |
|
candida-tropicalis-genetics |
2 |
|
candidiasis - complications |
2 |
|
candidiasis - drug therapy |
2 |
|
candidiasis - drug therapy - epidemiology - microbiology |
2 |
|
candidiasis, oral - complications |
2 |
|
candidiasis, oral - epidemiology - microbiology - physiopathology |
2 |
|
candidiasis, oral - ethnology - etiology |
2 |
|
candidiasis, oral - etiology - microbiology |
2 |
|
candidiasis, oral - immunology - pathology |
2 |
|
candidiasis, oral - microbiology - physiopathology |
2 |
|
candidiasis,-oral-epidemiology |
2 |
|
candidiasis,-oral-microbiology |
2 |
|
candy |
2 |
|
carbohydrate |
2 |
|
carbohydrates |
2 |
|
carbohydrates - pharmacology |
2 |
|
caries-affected dentine |
2 |
|
caries-associated microflora |
2 |
|
cariogenicity and artificial caries |
2 |
|
catheters |
2 |
|
cattle |
2 |
|
cd4 lymphocyte count |
2 |
|
cell adhesion - physiology |
2 |
|
cell count |
2 |
|
cell culture techniques |
2 |
|
cell line, tumor |
2 |
|
cell membrane - physiology |
2 |
|
cell-surface-hydrophobicity |
2 |
|
cells, cultured |
2 |
|
centers for disease control and prevention (u.s.) |
2 |
|
cheilitis - complications - microbiology - pathology |
2 |
|
chemomechanical caries removal |
2 |
|
chemoprophylaxis |
2 |
|
chlorhexidine - analogs & derivatives - pharmacology |
2 |
|
chronic disease |
2 |
|
chronic periodontitis - etiology - immunology |
2 |
|
coculture techniques |
2 |
|
colonization |
2 |
|
computer simulation |
2 |
|
covid-19 |
2 |
|
cricetinae |
2 |
|
culicidae - parasitology |
2 |
|
cultural deprivation |
2 |
|
culture |
2 |
|
curriculum |
2 |
|
cytoplasm - ultrastructure |
2 |
|
databases, factual |
2 |
|
demography |
2 |
|
dental caries - etiology - microbiology |
2 |
|
dental caries - metabolism - microbiology |
2 |
|
dental caries - therapy |
2 |
|
dental caries activity tests |
2 |
|
dental cavity preparation - instrumentation |
2 |
|
dental equipment |
2 |
|
dental high-speed equipment |
2 |
|
dental instruments |
2 |
|
dental plaque |
2 |
|
dental plaque - metabolism - microbiology |
2 |
|
dental pulp cavity - drug effects - microbiology |
2 |
|
dental research |
2 |
|
dental research - methods |
2 |
|
dental staff |
2 |
|
dentinal tubule |
2 |
|
disease |
2 |
|
disinfection - methods |
2 |
|
dna fingerprinting |
2 |
|
dna primers - genetics |
2 |
|
dna, bacterial - analysis - genetics |
2 |
|
dna, bacterial - genetics - metabolism |
2 |
|
dna, fungal - genetics |
2 |
|
dna, fungal - genetics - isolation & purification |
2 |
|
dna, ribosomal - genetics |
2 |
|
dna-fingerprinting |
2 |
|
drug evaluation, preclinical |
2 |
|
drug interaction |
2 |
|
drug interactions |
2 |
|
drug resistance, microbial |
2 |
|
drug therapy, combination |
2 |
|
dual species biofilm |
2 |
|
dynamic |
2 |
|
ebolavirus - physiology |
2 |
|
education, dental - organization & administration |
2 |
|
endocarditis, bacterial |
2 |
|
endocarditis, bacterial - prevention & control |
2 |
|
endodontic bacteria |
2 |
|
endodontic infection |
2 |
|
endodontic microbiology |
2 |
|
endodontic therapy |
2 |
|
endophthalmitis - drug therapy - epidemiology - microbiology |
2 |
|
england - epidemiology |
2 |
|
enterobacter cloacae - isolation & purification |
2 |
|
enterobacteriaceae - cytology - isolation & purification |
2 |
|
enterobacteriaceae - pathogenicity |
2 |
|
enzyme activation - drug effects |
2 |
|
epithelium - drug effects - immunology - metabolism - pathology |
2 |
|
epithelium - immunology - microbiology |
2 |
|
epithelium - microbiology - physiology |
2 |
|
epithelium - pathology |
2 |
|
epitopes |
2 |
|
equipment contamination - prevention & control |
2 |
|
escherichia |
2 |
|
escherichia coli |
2 |
|
escherichia coli - cytology - drug effects - physiology |
2 |
|
evolution |
2 |
|
exodeoxyribonucleases - antagonists and inhibitors - metabolism |
2 |
|
extracellular matrix - physiology |
2 |
|
extracellular space |
2 |
|
extracellular space - drug effects - enzymology |
2 |
|
eye infections, fungal - drug therapy - epidemiology - microbiology |
2 |
|
family |
2 |
|
fimbriae, bacterial - physiology |
2 |
|
fingerprinting |
2 |
|
fixed orthodontic appliance |
2 |
|
flow rate |
2 |
|
fluconazole resistance |
2 |
|
fluconazole-resistance |
2 |
|
food habits |
2 |
|
framycetin - therapeutic use |
2 |
|
framycetin sulfate |
2 |
|
fungal proteins - genetics |
2 |
|
fungal proteins - genetics - metabolism |
2 |
|
galactose - pharmacology |
2 |
|
gene expression - physiology |
2 |
|
gene expression regulation - drug effects - immunology |
2 |
|
gene expression regulation, enzymologic |
2 |
|
gene expression regulation, fungal - drug effects |
2 |
|
genes, fungal |
2 |
|
genes, recessive |
2 |
|
genetic diversity |
2 |
|
genome, fungal |
2 |
|
germany - epidemiology |
2 |
|
gingiva - microbiology - pathology |
2 |
|
gingiva - pathology |
2 |
|
gingival epithelia |
2 |
|
glucose - pharmacology |
2 |
|
gram-positive bacteria - physiology |
2 |
|
granulation tissue - pathology |
2 |
|
great britain |
2 |
|
haart |
2 |
|
health behavior |
2 |
|
health education |
2 |
|
hemolysin |
2 |
|
hemolysin proteins - metabolism |
2 |
|
hemorrhagic fever, ebola - diagnosis - prevention & control - therapy - transmission |
2 |
|
heterozygote |
2 |
|
histochemistry |
2 |
|
histocytochemistry |
2 |
|
hiv |
2 |
|
hiv infections - complications - drug therapy - ethnology - pathology |
2 |
|
hiv infections - complications - physiopathology |
2 |
|
hiv infections - enzymology |
2 |
|
hiv infections - microbiology - pathology |
2 |
|
hiv infections - prevention & control - transmission |
2 |
|
hiv infections - transmission |
2 |
|
hiv-1 |
2 |
|
homosexuality |
2 |
|
homosexuality, male |
2 |
|
hong kong chinese |
2 |
|
host-microbial interactions |
2 |
|
host-pathogen interactions |
2 |
|
human β-defensin-3 |
2 |
|
human β-defensins |
2 |
|
hybridization |
2 |
|
hydrophobic and hydrophilic interactions |
2 |
|
hydrophobicity |
2 |
|
hyphae - genetics |
2 |
|
hyphae - genetics - growth & development |
2 |
|
hyphae - physiology |
2 |
|
hyphae - physiology - ultrastructure |
2 |
|
hyphal mutants |
2 |
|
immune reconstitution inflammatory syndrome |
2 |
|
immune reconstitution inflammatory syndrome - complications - diagnosis - etiology - therapy |
2 |
|
immunity, innate |
2 |
|
in situ hybridization |
2 |
|
incubation conditions |
2 |
|
infection and serum-plasma |
2 |
|
infection control |
2 |
|
infection control - methods |
2 |
|
infection control, dental - methods |
2 |
|
infectious disease transmission, patient-to-professional |
2 |
|
infectious disease transmission, professional-to-patient |
2 |
|
information services |
2 |
|
intercellular junctions - microbiology |
2 |
|
interface |
2 |
|
interleukin-1alpha - analysis |
2 |
|
interleukin-8 - analysis |
2 |
|
intermediate filament proteins - analysis |
2 |
|
internalization |
2 |
|
international |
2 |
|
international cooperation |
2 |
|
introns |
2 |
|
isoenzymes - biosynthesis - genetics |
2 |
|
iysozyme |
2 |
|
karyotyping |
2 |
|
keratin-20 |
2 |
|
keratinocytes |
2 |
|
keratinocytes - cytology - microbiology - physiology |
2 |
|
keratinocytes - pathology |
2 |
|
keratins - genetics |
2 |
|
lactobacillus - growth & development - metabolism - pathogenicity |
2 |
|
lactobacillus - isolation & purification |
2 |
|
lactoferrin |
2 |
|
lactose - pharmacology |
2 |
|
langerhans cells - pathology |
2 |
|
leprosy - microbiology |
2 |
|
leukoplakia, hairy - ethnology - etiology |
2 |
|
leukoplakia, oral - etiology |
2 |
|
linear models |
2 |
|
lipid a - analogs & derivatives - pharmacology |
2 |
|
lysophospholipase - analysis |
2 |
|
lysophospholipase - metabolism |
2 |
|
malaria - immunology |
2 |
|
maltose - pharmacology |
2 |
|
management information systems |
2 |
|
media |
2 |
|
merkel cells - pathology |
2 |
|
metallothionein |
2 |
|
microbial biotechnology |
2 |
|
microbial invasion |
2 |
|
microbiological techniques |
2 |
